Scientists scan brains of people with autism and Fragile-X to uncover clues
NCT ID NCT02719951
First seen Jan 10, 2026 · Last updated May 15, 2026 · Updated 13 times
Summary
This study used a special brain scan (PET imaging) to measure a chemical messenger called glutamate in 27 men with autism, Fragile-X syndrome, or no condition. The goal was to see how brain signaling differs between these groups. No treatment was given; it was purely an observation study to better understand these conditions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Tours
Tours, 37044, France
Conditions
Explore the condition pages connected to this study.